Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Alphamab Applies for the Marketing of a Subcutaneous Broad-Spectrum Anti-PD-L1 Monoclonal Antibody Against Cancers

PharmaSources/XiaoyaowanDecember 08, 2020

Tag: Anti-PD-L1 antibody , subcutaneous injection

PharmaSources Customer Service